(Q44245951)

1 December 2017

title

Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy (English)

1 reference

1 December 2017

Shimada K

1

1 reference

1 December 2017

Baba T

2

1 reference

1 December 2017

Neugebauer S

3

1 reference

1 December 2017

Onozaki A

4

1 reference

1 December 2017

Yamada D

5

1 reference

1 December 2017

Midorikawa S

6

1 reference

1 December 2017

Sato W

7

1 reference

1 December 2017

Watanabe T

8

1 reference

1 December 2017

publication date

1 November 2002

1 reference

Journal of Diabetes and its Complications

1 December 2017

published in

1 reference

1 December 2017

volume

16

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

386-390

1 reference

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Modulation of VEGF production by pH and glucose in retinal Müller cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Pathogenesis, prevention, and treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900162-9

7 January 2021

10.1016/S1056-8727(02)00162-9

Identifiers

DOI

1 reference

release_xfazu34b5zcb3eugbsvhpxlfuq

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfazu34b5zcb3eugbsvhpxlfuq

24 November 2022

mapped directly with Wikidata item

1 reference